Amy Stobie
Comment & OpinionRetailers are sleepwalking into the ‘Club Ozempic’ era
As 8.25 million Britons take or consider GLP-1 medications, retailers from Boots to Ocado are racing to work out what ‘Club Ozempic’ shoppers actually want, says Amy Stobie, co-founder and commercial director at AgencyUK